GT Biopharma, Inc. (GTBP)
0.4399
+0.01
(+3.51%)
USD |
NASDAQ |
Mar 13, 09:37
GT Biopharma Shareholders Equity (Quarterly) : 5.787M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lyell Immunopharma, Inc. | 329.12M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| SELLAS Life Sciences Group, Inc. | 45.63M |
| Crinetics Pharmaceuticals, Inc. | 992.08M |
| Sutro Biopharma, Inc. | -87.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.106M |
| Total Liabilities (Quarterly) | 2.319M |
| Current Ratio | 3.222 |